Literature DB >> 15168143

The prevalence of subclinical amyloidosis in Polish patients with rheumatoid arthritis.

Piotr Wiland1, Renata Wojtala, John Goodacre, Jacek Szechinski.   

Abstract

The aims of this study were to determine the proportion of rheumatoid arthritis (RA) patients attending hospital in whom amyloid deposits were present in abdominal fat aspiration (AFA) samples, and to assess possible risk factors for amyloid development in RA. One -hundred and twenty-one patients (16 males, 105 females) with RA referred to the Department of Rheumatology in Wroclaw between 1996 and 2001 were studied regardless of RA duration or laboratory findings. Abdominal subcutaneous fine-needle aspiration was performed, and samples of adipose tissue stained with alkaline Congo red then examined by polarized light microscopy. The presence or absence of amyloid fat deposits (AFD) was determined according to whether typical apple-green birefringence was observed. Amyloid deposits were found in 35 (29%) patients. Amyloidosis was significantly more common in males and in patients with longer disease duration. Patients with AFD had previously undergone less treatment with disease-modifying antirheumatic drugs (DMARDs) than those without AFD, and significantly fewer patients with AFD had previously taken methotrexate than those without AFD (25% vs 45%; p<0.01). Renal involvement was found in 12 of 35 patients with AFD (34%). Using the AFA technique, amyloid deposits were found commonly in RA patients, particularly in males with longer disease duration and in patients not treated intensively with DMARDs, especially methotrexate. AFA has potential useful application as a method for detecting amyloidosis before the overt occurrence of renal or other pathology related to amyloid deposits.

Entities:  

Mesh:

Year:  2004        PMID: 15168143     DOI: 10.1007/s10067-003-0842-y

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  31 in total

1.  Secondary amyloidosis has decreased in patients with inflammatory joint disease in Finland.

Authors:  K Laiho; S Tiitinen; K Kaarela; H Helin; H Isomäki
Journal:  Clin Rheumatol       Date:  1999       Impact factor: 2.980

2.  Intensive treatment of rheumatoid arthritis reduces need for dialysis due to secondary amyloidosis.

Authors:  O Kaipiainen-Seppänen; R Myllykangas-Luosujärvi; E Lampainen; R Ikäheimo
Journal:  Scand J Rheumatol       Date:  2000       Impact factor: 3.641

3.  Development of amyloidosis as an unrecognized side effect of gold therapy: comment on the article by Shapiro and Spiera.

Authors:  H Michels; R P Linke
Journal:  Arthritis Rheum       Date:  1996-11

4.  Fine-needle aspiration biopsy from subcutaneous fat. An easy way to diagnose secondary amyloidosis.

Authors:  P J Klemi; S Sorsa; R P Happonen
Journal:  Scand J Rheumatol       Date:  1987       Impact factor: 3.641

5.  Survival study of rheumatoid arthritis patients in Madrid (Spain). A 9-year prospective follow-up.

Authors:  M S Martínez; A García-Monforte; J Rivera
Journal:  Scand J Rheumatol       Date:  2001       Impact factor: 3.641

6.  The clinical significance of amyloid fat deposits in rheumatoid arthritis: a systematic long-term followup study using abdominal fat aspiration.

Authors:  E Gómez-Casanovas; R Sanmartí; M Solé; J D Cañete; J Muñoz-Gómez
Journal:  Arthritis Rheum       Date:  2001-01

7.  Screening for amyloid in subcutaneous fat tissue of Egyptian patients with rheumatoid arthritis: clinical and laboratory characteristics.

Authors:  T M El Mansoury; B P C Hazenberg; S A El Badawy; A H Ahmed; J Bijzet; P C Limburg; M H van Rijswijk
Journal:  Ann Rheum Dis       Date:  2002-01       Impact factor: 19.103

8.  Amyloidosis--incidence and early risk factors in patients with rheumatoid arthritis.

Authors:  S Tiitinen; K Kaarela; H Helin; H Kautiainen; H Isomäki
Journal:  Scand J Rheumatol       Date:  1993       Impact factor: 3.641

9.  Results, principles and pitfalls in the management of renal AA-amyloidosis; a 10-21 year followup of 16 patients with rheumatic disease treated with alkylating cytostatics.

Authors:  K Berglund; H Thysell; C Keller
Journal:  J Rheumatol       Date:  1993-12       Impact factor: 4.666

10.  Proteinuria in rheumatoid arthritis--drug-induced or amyloid?

Authors:  B E Bourke; D F Woodrow; J T Scott
Journal:  Ann Rheum Dis       Date:  1981-06       Impact factor: 19.103

View more
  4 in total

Review 1.  Systemic amyloidosis: a challenge for the rheumatologist.

Authors:  Federico Perfetto; Alberto Moggi-Pignone; Riccardo Livi; Alessio Tempestini; Franco Bergesio; Marco Matucci-Cerinic
Journal:  Nat Rev Rheumatol       Date:  2010-06-08       Impact factor: 20.543

Review 2.  Gastrointestinal and Hepatic Disease in Rheumatoid Arthritis.

Authors:  Ethan Craig; Laura C Cappelli
Journal:  Rheum Dis Clin North Am       Date:  2018-02       Impact factor: 2.670

3.  Intestinal Amyloidosis in Common Variable Immunodeficiency and Rheumatoid Arthritis.

Authors:  T Meira; R Sousa; A Cordeiro; R Ilgenfritz; P Borralho
Journal:  Case Rep Gastrointest Med       Date:  2015-08-16

4.  Elevated Peripheral T Helper Cells Are Associated With Atrial Fibrillation in Patients With Rheumatoid Arthritis.

Authors:  Xin Wang; Hongxuan Fan; Yongle Wang; Xufang Yin; Guangying Liu; Chong Gao; Xiaofeng Li; Bin Liang
Journal:  Front Immunol       Date:  2021-10-15       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.